Here is an example of how our foundations could work together for PD research:

More and more life sciences companies find themselves intrigued by the idea of receiving investments from patient advocacy or disease foundations. But few startups understand the realities of how those organizations dole out awards — and how intricately structured those deals can be.

Whereas philanthropy organizations once supported academic research only, many are now looking to industry for cures. While the number of such financing deals are increasing, biotechs beware: They are not for the faint of heart, say experts.

The logic is sound enough: Foundations seeking cures to debilitating diseases such as cystic fibrosis, muscular dystrophy and Parkinson’s disease want to fund promising research in the private sector.

http://www.masshightech.com/stories/...undations.html